Patients with multiple sclerosis experience decreased connectivity between brain regions leading to the cognitive changes that are a trademark of the disease, according to research published in Neuropsychology.
To keep their minds sharp, older people are often advised to take vitamins or other dietary supplements and to engage in regular exercise.
Two studies in JAMA show those practices had no effect on cognitive function.
There are 12 medications for multiple sclerosis and no treatment algorithm. This adds up to several decisions to make when initiating treatment. The panelists offer their thoughts on how to select a treatment for an individual patient.
With several newer agents on the market to treat multiple sclerosis, it can be hard to keep track of all of their data. Here, Dr. Dhib-Jalbut and the other panelists consolidate the key characteristics of the three oral agents for multiple sclerosis.
While alemtuzumab is extremely potent and effective in treating multiple sclerosis with an attractive dosing schedule, it also is associated with safety risks and a risk mitigation plan. Find out the details of both sides here from Dr. Lublin and the other panelists.
Here, the panelists summarize the latest clinical trial data for pegylated interferon beta-1a for the treatment of multiple sclerosis, which offers a less frequent dosing schedule than the older interferon betas.